Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis

Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis

Mostra altre versioni (1)

Cryptosporidiosis is a neglected disease without a wholly effective drug. We present a study demonstrating nitrogen-containing bisphosphonates (N-BPs) to be capable of inhibiting Cryptosporidium parvum at low micromolar concentrations in infected MDCK cells. Predictably, the mechanism of action is b...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Artz, J, Dunford, J, Arrowood, M, Dong, A, Chruszcz, M, Kavanagh, K, Minor, W, Russell, R, Ebetino, F, Oppermann, U, Hui, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008
Soggetti:	Dimethylallyltranstransferase Fluorescent Antibody Technique Cryptosporidiosis Models, Molecular Chromatography, Liquid Crystallography, X-Ray Diphosphonates Anti-Infective Agents pharmacology therapeutic use enzymology antagonists and inhibitors Cattle Cells, Cultured Molecular Structure drug therapy Inhibitory Concentration 50 metabolism Cryptosporidium parvum drug effects Protein Prenylation

Documenti analoghi

CRYPTOSPORIDIOSIS IN PEDIATRIC PATIENTS
di: Nélida SAREDI, et al.
Pubblicazione: (1998-05-01)

Health sequelae of human cryptosporidiosis in industrialised countries: a systematic review
di: Bethan L. Carter, et al.
Pubblicazione: (2020-09-01)

Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.
di: Artz, J, et al.
Pubblicazione: (2008)

Successful experimental infant baboon model for childhood cryptosporidiosis studies
di: Ngalla E. Jillani, et al.
Pubblicazione: (2021-06-01)

Cryptosporidium and cryptosporidiosis /
di: Fayer, Ronald., editor, et al.
Pubblicazione: (2008)

Foot and Mouth Disease and Cryptosporidiosis: Possible Interaction between Two Emerging Infectious Diseases
di: Paul R. Hunter, et al.
Pubblicazione: (2003-01-01)

Size of Cryptosporidium oocysts excreted by symptomatic children of Santiago, Chile
di: R. Mercado, et al.
Pubblicazione: (1995-10-01)

Infection by Cryptosporidium parvum in renal patients submitted to renal transplant or hemodialysis
di: Chieffi Pedro Paulo, et al.
Pubblicazione: (1998-01-01)

INTESTINAL AND PULMONARY INFECTION BY Cryptosporidium parvum IN TWO PATIENTS WITH HIV/AIDS
di: Fábio Tadeu Rodrigues REINA, et al.
Pubblicazione: (2016-01-01)

Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice
di: Karine eSonzogni-Desautels, et al.
Pubblicazione: (2015-09-01)

CRYPTOSPORIDIOSIS IN CHILDREN – CLINICAL FORMS AND CLINICAL CASES
di: Kalina Stoyanova
Pubblicazione: (2020-03-01)

Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review
di: Shahbaz M. Khan, et al.
Pubblicazione: (2023-01-01)

Genotypic identification of Cryptosporidium spp. isolated from hiv-infected patients and immunocompetent children of São Paulo, Brazil Identificação genotípica de Cryptosporidium spp. isolados a partir de pacientes com HIV e crianças imunocompetentes de São Paulo, Brasil
di: Ana Julia Urias dos Santos Araújo, et al.
Pubblicazione: (2008-06-01)

Study of Cryptosporidium in children below five years of age with diarrhea in referring Ali-Asghar Pediatric Hospital of Zahedan
di: M.Dabirzadeh (M.Sc), et al.
Pubblicazione: (2003-03-01)

Genetic diversity and shedding profiles for Cryptosporidium parvum in adult cattle and their calves
di: Hannah Jade Shaw, et al.
Pubblicazione: (2021-01-01)

Novel Cryptosporidium Genotypes in Sporadic Cryptosporidiosis Cases: First Report of Human Infections with a Cervine Genotype
di: Corinne S. L. Ong, et al.
Pubblicazione: (2002-03-01)

Cryptosporidiosis among patients with acquired immunodeficiency syndrome (AIDS) in the county of São Paulo, Brazil
di: Rosa Maria Donini Souza Dias, et al.
Pubblicazione: (1988-08-01)

Current status and challenges in drug discovery against the globally important zoonotic cryptosporidiosis
di: Guan Zhu, et al.
Pubblicazione: (2021-04-01)

Prevalence, risk factors and molecular epidemiology of neonatal cryptosporidiosis in calves: The Argentine perspective
di: Paloma de Alba, et al.
Pubblicazione: (2023-01-01)

SEASONAL DYNAMICS OF PIGLET INVASION BY CRYPTOSPORIDIUM PARVUM UNDER CONDITIONS OF INDUSTRIAL PIG FARMING IN VOLOGDA REGION
di: A. S. Novikov, et al.
Pubblicazione: (2016-05-01)

Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review
di: M. Martinot, et al.
Pubblicazione: (2020-03-01)

Prevalence of Cryptosporidiosis in Calves and Efficiency of ELISA in Detection of The Infection Compared with Some Traditional Methods
di: Muna M. Khalil
Pubblicazione: (2011-12-01)

Rhizomucor miehei lipase supported on chitosan-graphene oxide beads for the production of geraniol propionate /
di: Isah Abdurrahman Adamu, 1983- , author, et al.
Pubblicazione: (2015)

Rhizomucor miehei lipase supported on chitosan-graphene oxide beads for the production of geraniol propionate [electronic resource] /
di: Isah Abdurrahman Adamu, 1983-
Pubblicazione: (2015)

Detection of Cryptosporidium parvum by modified acid-fast stain among cancer patients in Thi-Qar province
di: Zahraa alsafi, et al.
Pubblicazione: (2023-12-01)

Metabolic Signatures of <i>Cryptosporidium</i> <i>parvum</i>-Infected HCT-8 Cells and Impact of Selected Metabolic Inhibitors on <i>C. parvum</i> Infection under Physioxia and Hyperoxia
di: Juan Vélez, et al.
Pubblicazione: (2021-01-01)

Specific pathway abundances in the neonatal calf faecal microbiome are associated with susceptibility to Cryptosporidium parvum infection: a metagenomic analysis
di: M. F. Hares, et al.
Pubblicazione: (2023-09-01)

Progression of the faecal microbiome in preweaning dairy calves that develop cryptosporidiosis
di: M. F. Hares, et al.
Pubblicazione: (2025-01-01)

Cryptosporidium hominis Infection of the Human Respiratory Tract
di: Rubén Mercado, et al.
Pubblicazione: (2007-03-01)

Cryptosporidiosis and Filtration of Water from Loch Lomond, Scotland
di: Kevin G.J. Pollock, et al.
Pubblicazione: (2008-01-01)

First molecular investigation of Cryptosporidium spp. in young calves in Algeria
di: Benhouda Djahida, et al.
Pubblicazione: (2017-01-01)

Analysis of the Cryptosporidium spp. and gp60 subtypes linked to human outbreaks of cryptosporidiosis in England and Wales, 2009 to 2017
di: Rachel M. Chalmers, et al.
Pubblicazione: (2019-03-01)

Identification and Evaluation of Cryptosporidium Species from New York City Cases of Cryptosporidiosis (2015 to 2018): a Watershed Perspective
di: Kerri A. Alderisio, et al.
Pubblicazione: (2023-02-01)

Extended Outbreak of Cryptosporidiosis in a Pediatric Hospital, China
di: Yaoyu Feng, et al.
Pubblicazione: (2012-02-01)

Cryptosporidiosis Decline after Regulation, England and Wales, 1989–2005
di: Iain R. Lake, et al.
Pubblicazione: (2007-04-01)

Molecular prevalence and associated risk factors of Cryptosporidium spp. infection in dairy cattle in Khon Kaen, Thailand
di: Bamphen Keomoungkhoun, et al.
Pubblicazione: (2024-02-01)

Possible zoonotic transmission of Cryptosporidium felis in a household
di: Jessica Beser, et al.
Pubblicazione: (2015-10-01)

Microbiome diversity is a modifiable virulence factor for cryptosporidiosis
di: Georgina. R. Hurle, et al.
Pubblicazione: (2023-12-01)

Investigating differential expression genes profile in HCT-8 cell line infected with Cryptosporidium parvum in host-parasite interactions
di: S. Dadkhah Tehrani, et al.
Pubblicazione: (2024-09-01)

The first commercially approved efficacious cryptosporidium vaccine protecting New-Born calves from severe diarrhea
di: Marina Timmermans, et al.
Pubblicazione: (2024-03-01)